SMTL ID : 4rj3.1

CDK2 with EGFR inhibitor compound 8

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.63 Å

Oligo State

monomer

Ligands

1 x ACT: ACETATE ION(Non-functional Binders)

ACT.1: 6 residues within 4Å: Chain A: K.129, Q.131, E.162, V.163, V.164, T.165 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:K.129, A:T.165 Hydrogen bonds: A:T.165 Salt bridges: A:K.129

1 x 3QS: 1-cyclopentyl-N-[2-(4-methoxypiperidin-1-yl)pyrimidin-4-yl]-1H-pyrrolo[3,2-c]pyridin-6-amine(Non-covalent)

3QS.2: 18 residues within 4Å: Chain A: I.10, E.12, V.18, A.31, K.33, V.64, F.80, E.81, F.82, L.83, H.84, Q.85, D.86, Q.131, N.132, L.134, A.144, D.145 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:I.10, A:V.18, A:A.31, A:V.64, A:F.80, A:N.132, A:A.144 Hydrogen bonds: A:E.12, A:L.83, A:L.83 Water bridges: A:D.86

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hanan, E.J. et al., Discovery of Selective and Noncovalent Diaminopyrimidine-Based Inhibitors of Epidermal Growth Factor Receptor Containing the T790M Resistance Mutation. J.Med.Chem. (2014)

Release Date

2014-11-26

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2

Related Entries With Identical Sequence